Skip to content
Disclosery

EXANE DERIVATIVES: LLY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on LLY, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 790 LLY shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 790 shares
    Change vs previous 13F -1,691 shares

    0.15% of the 13F portfolio, value $256,108.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,481 shares
    Change vs previous 13F +688 shares

    0.2% of the 13F portfolio, value $710,489.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,793 shares
    Change vs previous 13F +43 shares

    0.12% of the 13F portfolio, value $495,278.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,750 shares
    Change vs previous 13F +252 shares

    0.1% of the 13F portfolio, value $404,353.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,498 shares
    Change vs previous 13F +101 shares

    0.08% of the 13F portfolio, value $352,487.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,397 shares
    Change vs previous 13F -2,653 shares

    0.08% of the 13F portfolio, value $261,000.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 4,050 shares
    Change vs previous 13F +2,932 shares

    0.21% of the 13F portfolio, value $683,832.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,118 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $165,491.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).